tiprankstipranks
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD

Compare Tvardi Therapeutics (TVRD) vs. Competitors

2,524 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Tvardi Therapeutics
$3.05
$28.61M
-1.75
-79.04%
4 Buy
3 Hold
0 Sell
Moderate Buy
Plus Therapeutics
$0.58
$21.75M
-1.78
-84.15%
3 Buy
1 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.34
$26.74M
5.20
-55.75%
Aligos Therapeutics
$7.99
$49.44M
-1.22
69.64%
3 Buy
0 Hold
0 Sell
Strong Buy
Genenta Science SpA Sponsored ADR
$1.45
$16.58M
-3.17
-80.15%
Adlai Nortye Ltd. Sponsored ADR
$12.03
$443.91M
550.62%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVRD
Tvardi Therapeutics
3.05
-11.54
-79.10%
PSTV
Plus Therapeutics
3.17
-16.51
-83.89%
CUE
Cue Biopharma
0.27
-0.44
-61.98%
ALGS
Aligos Therapeutics
7.99
4.00
100.25%
GNTA
Genenta Science SpA Sponsored ADR
0.71
-3.09
-81.39%
ANL
Adlai Nortye Ltd. Sponsored ADR
12.03
10.14
536.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts